CPHI Webinar Series

The Future of Biomanufacturing: Capacity, Capability and Careers

February 22, 2022
4pm CET / 10am EST
What will this webinar address?

There is more emphasis than ever before on biopharma innovation – a sentiment heightened by the speed at which the industry came together to develop vaccines for COVID-19 – setting new expectations for the future.

With development comes fulfillment, and with biomanufacturing capacity at an all-time low, what infrastructure is needed to keep pace with innovation?

This webinar will provide an overview of biopharma trends and technologies, and address challenges around supply chain, capacity and workforce, to ensure continued productivity, efficiency, and output in the biomanufacturing sector.

Key discussion points
  • Biopharmaceutical landscape outlook - what are the short and long-term impacts of COVID-19?
  • Rising trends and technologies – mRNA, immunology, and vaccines
  • Building flexible manufacturing networks and increasing capacity
  • Single-use tech availability
  • Training the workforce of the future
Why attend?
  • Get a complete overview of trends, opportunities, and disruptions in the biomanufacturing sector, in just 60 minutes.
  • Hear from experts on shaping biomanufacturing strategies to meet industry needs.
  • Put your questions to our speakers during the live Q&A session
Killian O'Driscoll
Director of Projects
National Institute for Bioprocessing Research and Training (NIBRT)

Killian O’Driscoll is the Director of Projects at the National Institute for Bioprocessing Research and Training (NIBRT). Killian is a Genetics Graduate from Trinity College Dublin with an MSc in the Management of Innovation from the University of London. He also is an Associate Lecturer in Project Management at Dublin Business School

Prior to joining NIBRT, Killian worked with Microsoft European Operations Centre as Senior Global Project Manager and with Ericsson Competence Development Centre in the area of technology education and development.

Killian working closely with all stakeholders in the biopharmaceutical industry has been involved in the successful establishment of NIBRT which has numerous international accolades including ISPE Facility of The Year, Bioprocess International Manufacturing Collaboration of the Decade and NIBRT is now recognized as a global leader in biopharma research and training.

Eric Langer
President and Managing Partner
Bioplan Associates, Inc

Eric Langer, President and Managing Partner, has over 20 years’ experience in biotechnology and life sciences international marketing, management, market assessment, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies.

He is an experienced biotechnology strategist, marketing practitioner, publisher, and researcher. He has published, edited and authored numerous books, reports, and major studies on topics including: Advances in Biopharmaceutical Technology in China, Advances in Large-scale Biopharmaceutical Manufacturing, Biopharmaceuticals in the US Market, cell culture reports, media, sera, tissue engineering, stem cells, diagnostic products, blood products, genetics, DNA/PCR purification, blood components, and many others.

He lectures extensively on marketing, pricing and channel management topics, and teaches at Johns Hopkins University and American University: Biotechnology Marketing, Marketing Management, Services Marketing, Advertising Strategy, and Bioscience Communication.

In 1989 he co-founded BioPlan Associates, Inc. He has launched and managed marketing programs for product lines ranging from $500k to $500 million.

The Future of Biomanufacturing: Capacity, Capability and Careers
  • February 22, 2022
  • 4pm CET / 10am EST
  • 60 minutes
  • Free
CPHI Newsletter

Get the latest from CPHI in your inbox every week.

You understand that your information will be used in accordance with our Privacy Policy, and that you may withdraw your permission to receive any of our communications at any time by clicking on the Unsubscribe link in the Newsletters or opting out on our unsubscribe page page.